1. This project has three objectives: prediction of disability, admission to hospital and death in patients with CHF. In the Background section there are mentions to other research works, but many papers are referred to readmissions and even some of them analyze populations of patients with chronic diseases, but not specifically CHF. In my opinion, it should be given relevance to the works more closely related to the objectives of the study and reducing the references to other predictive models. In any case, the authors should indicate clearly whether the studies are referred to readmissions (which are generally already done) and especially if they involve patients with chronic diseases in general.
2. The description of the Johns Hopkins ACG-pm system does not provide useful information in this point and the paragraph should be excluded. It is true that the patient classification systems (ACGs and others) provide predictions about future populations care needs. However, its structure is so different from the predictive model that the authors intend to design that a comparison is not justified. In addition, they are usually used in the stratification of a complete population (not exclusively in patients with a particular pathology and selected by primary physicians, such in this study). On the other hand, some of the included statements are not correct: ACGs do not categorize patients "according to the health care required in the previous year" (page 6, line 48), and there are many research studies and real world applications of ACGs in absence of claim data (page 7, lines 2-7) that have been published for more than ten years.
3. The description of the study variables is not easy to understand for the reader and needs to be reorganized. References to some variables of the study appear on page 10 and following (Patients' recruitment, initial visit, sampling size) but their descriptions are not given until pages 12 and 13. There are also several acronyms without description the first time used and acronyms in Spanish.
4. It is not clear to me how the disability is going to be analyzed. At the beginning and at the end of the study period, WHODAS 2.0 will be applied to all the included patients. According to the result of the second measurement they will be classified in levels (from low to extreme) as it is explained in "Dependent variables". It is intuitive to think that the disability level at the end of the study will be closely related to the baseline situation. However, the use of the data from the first evaluation is not described. Will they be used as an independent variable? Will the patients be analyzed separately in subgroups according to their basal disability? The dependent variable is really the transition to higher disability? Difference in disability scores at the beginning and end of the studio?
5. The risk of hospital admission is closely related to previous hospitalizations. However, it is not included among the explanatory variables Other comments:
-In "strengths and limitations" is stated that "most admissions will carry out in a unique hospital". However, in page 10, line 7 there is a said that there are "two reference hospitals". A clarification is needed.
-Page 8 -Main objective: in my view, the expression "Hospitalization needs" should be changed to "risk of hospitalization".
-Secondary objectives#2, 3, 4: the expression "in the first monitoring year" is confusing. If I've deduced correctly it should be changed by "at the end of the study period" or "after one year monitoring" -It seems redundant to repeat "over 18 years" in study population and in inclusion criteria.
-Inclusion criteria: there are two ways to be included in the study, but I don't see the real difference. The first one will select patients with symptoms, signs and echography or other test to confirm the alteration in cardiac function. The second one is for patients having undergone an echographic study and also fulfilling the previous criteria. ¿What is the difference? -Page 10: Patients' recruitment. From the point of view of the objectives of this study I don't see the relevance of differing prevalent and incident cases. Anyway, there is not any subsequent reference to prevalent/incident cases in "variables" or "analysis" sections, so in my opinion such sentence should be deleted. 
GENERAL COMMENTS
This is an interesting protocol trying to stratify HF patients based on their disability status, by a group with experience in risk stratification projects.
Regarding the design of the study, I would like to ask the authors whether the use of the WHOPAS 2 should be in the independent variables and not in the dependent. I am asking this, because, in general the older, the sicker the patients the higher disability status they will have. On the other hand, it would be interesting to see whether baseline WHOPAS2 score or the change from baseline at 1 year could predict mortality or rehospitalizations rate. I would also suggest to record and classify hospitalizations to cardiovascular vs non cardiovascular, and the cardiovascular one's to HF vs non-HF. Additionally, what would be the role of MLFHQ, since there would be a huge overlap with WHOPAS2? I would also advise to rephrase the main objective "and their hospitalization needs…….study" to make it more clear. Page 8, line 44-45 I would ask from the authors to reformat the structure of their manuscript to the journal's one, since it seems that they have used their grant proposal. Per journal's instructions there should be an Introduction, Methods, Analysis, Ethics and Dissemination etc. I would advise to have the inclusion/exclusion criteria numbered, for a better understanding.
Regarding the inclusion criteria page 9, line 35-36, "or relevant ……proBNP>300pg/ml", does this mean that a person with EF>50% who fulfills this criterion is eligible for the study? Minor Issues: Please explain the abbreviations before using them in the manuscript. The manuscript should be rechecked for typos and syntactical errors. 
This protocol is expected to allow development and validation of a stratification system, which will classify patients with chronic heart failure according to degree of disability and need of hospitalization. Although it has been properly designed, there are a few points that should be addressed: 1) The authors suggest a split-sample technique for validation of the predictive models. This method is referred to as "external validation". However, split sample is rather an internal validation technique, given that the validation cohort has originated directly from the study population.
2) Bootstrapping would be the preferable method for model internal validation. Thus, the calculated sample could be smaller and/or the number of predictors larger.
3) External validation could follow, with random samples drawn from different populations.
VERSION 1 -AUTHOR RESPONSE
REVIEWER 1: 1. The project has two main objectives, i.e., prediction of disability and prediction of hospitalization. We intend to analyze mortality as a secondary objective, since the sample size and expected followup incidence may not permit us to do this with reasonable accuracy. We have listed the studies that address prognostic models for patients with HF. 2. We agree with the reviewer's comment about the Johns Hopkins ACG-PM system, and the paragraph referred to by the reviewer has now been deleted. 3. We should like to thank the reviewer for his comment regarding the description of the study variables. The structure of the manuscript has been amended and, the description of the variables now appears at the beginning of the Methods and Analysis section. We trust that this change will render the manuscript that much more readable. 4. We should again like to thank the reviewer for his comment and have now clarified how the WHODAS 2 scale scores will be treated. In brief, the WHODAS 2 scale score will be treated as an independent variable in all models. On the other hand, it is the variable used to quantify disability at the end of follow-up and is therefore also a dependent variable. 5. We are grateful for and in agreement with the reviewer's comment regarding the role which previous hospitalizations may play in the results of the study. This information is available for all patients included in the study via the hospital MBDS, and will be included as an independent variable when it comes to constructing the prognostic models. 6. The study population has been served by a single referral hospital for the last 10 years. Until 2007, however, there was a different referral hospital. To avoid any possible loss of patients and data in a case where some patient might still be undergoing treatment at the former referral hospital, we have therefore decided to obtain the MBDS of the two hospitals. This situation has now been clarified in the manuscript. 7. The amendments suggested by the reviewer in other comments have been introduced: a. There is a single way of being included in the study. An echocardiography will be performed at the time of enrolment, if the patient has no prior echocardiographic study or this has been performed more than six months previously. b. Hospitalization data were obtained from the hospitals and primary care electronic medical records. These databases will be cross-referenced and will enable us to identify patients who have been admitted at hospitals other than the two from which the hospital MBDS are to be obtained. In the case of mortality, there will be no need to use the data shown on the primary care database: the mortality registry is comprehensive and will show information on all deaths that have occurred among the study patients. c. With respect to the use of other clinical variables, despite the fact that these will be available, we have nonetheless opted to lend more importance to quality of life, disability and socioeconomic level. d. As regards treatment of the EDCs in the modeling process, the number of EDCs and some EDCs that have been found to be relevant in other studies, e.g., ischemic heart disease, will be included as independent variables e. Framingham was erroneously included as an independent variable and has now been deleted. REVIEWER 2: 1. We agree with and should like to thank the reviewer for his comments. The WHODAS 2 scale score will be treated as an independent variable in all models, and will moreover be treated as a dependent variable in the prognostic models of disability. We have endeavored to clarify this in the manuscript.
2. The reviewer's proposal to separate hospitalizations into cardiovascular vs. non-cardiovascular and HF vs. non-HF, strikes us as an excellent suggestion. We shall take this into account in our analysis. 3. The manuscript has been restructured in line with the BMJ Open publication guidelines. 4. The inclusion/exclusion criteria have now been numbered. 5. With regard to the reviewer's comment about the inclusion criterion based on the determination of NPs, the inclusion criterion has now been redrafted in line with the recommendations contained in the ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. These Guidelines establish the following for diagnosis of HF with preserved ejection fraction (2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016; 37:2129-2200): a. 
GENERAL COMMENTS
The authors have been responsive to most of my comments.
However, on my view, the first one has been only partially answered. In their reply the authors sustain that: "We have listed the studies that address prognostic models for patients with HF." . This is not exact. For example, in page 4, line 42 they state: "Risk of hospital readmission in HF patients is poorly predicted by physicians ". It seems plausible that such assertion could be true but, on my knowledge, there are not published evidences of it. In fact, the presented reference (Allaudeen, 2011) corresponds to a cohort of elderly patients discharged from the University of California Medical Center, but not specifically HF patients. I have observed the same circumstance in other bibliographic references (17, 19, 22) .
Also, I have detected a mistake. Although in their response letter the authors have written that they will include previous hospital admissions as an independent variable, I cannot see such amendment in the last draft of their manuscript.
There is a very minor spelling mistake in the reference 23 (Murphy, 2011): "modelling" should be replaced by "modeling", because this is the variant spelling employed by Murphy and others. 
This is a well designed, and interesting prospective study addressing the need for a reliable risk prediction model and investigating the various factors affecting morbidity and mortality in Heart failure.
The revised manuscript is well structured and written.
MAJOR COMMENTS
After reading the restructured inclusion criteria, it was still difficult for me to distinguish the target population. It seems that you target people with HF with either HFrEF or HFmrEF. Maybe if you could mention the terms HFrEF and HFmrEF would facilitate this. Furthermore at page 10, I would rephrase lines 44-58, so that the HF criteria used from ESC guidelines are better explained. In page 2 lines 24-25, I would also replace "and left ventricular……dysfunction." With " and subjects with HFrEF and HFmrEF"
Minor Comments.
The limitations of the study are very well explained, but I would still add that since your population comes from the PCPs there is still a selection bias, but definitely it reflects in a better way general population than the hospital based studies.
Page 10 line 5, you mention two hospitals, while in all the other sections about only one hospital, and that this would also be an advantage.
It would be good to define exposed vs un exposed group based on the WHODAS score in page 13, where appropriate.
